BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/24/2025 8:23:47 AM | Browse: 2 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Pablo Guillermo Hernández-Almonacid and Ximena Marín-Quintero |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pablo Guillermo Hernández-Almonacid, Consultant, MD, Department of Internal Medicine, National University of Colombia, Kr 35 bis 60-45 A311, Bogota 111311, Colombia. pghernandezalm@gmail.com |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Artificial intelligence; Machine learning; Deep learning; Ultrasonography; Digital pathology; Hepatocellular carcinoma; Precision medicine |
| Core Tip |
Artificial intelligence (AI) is redefining the clinical approach to metabolic dysfunction-associated steatotic liver disease (MASLD). In diagnosis, it enhances the detection of steatosis and fibrosis beyond the limits of conventional tools. For prognosis, AI accurately stratifies risk and anticipates complications, consistently demonstrating superior performance. In treatment, it enables personalized interventions and accelerates drug development. By integrating multimodal data, including clinical, imaging, histopathological, and molecular information, AI transforms fragmented data into actionable insights, establishing itself as a cornerstone for the future of MASLD management. |
| Citation |
Hernández-Almonacid PG, Marín-Quintero X. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches. World J Gastroenterol 2025; In press |
 |
Received |
|
2025-07-08 01:34 |
 |
Peer-Review Started |
|
2025-07-08 01:34 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-08-25 07:51 |
 |
Revised |
|
2025-09-06 19:30 |
 |
Second Decision |
|
2025-11-24 02:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-11-24 08:23 |
 |
Articles in Press |
|
2025-11-24 08:23 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345